califf. you have an upcoming hearing on cellular tissue and gene therapies from the advisory committee concerning a new muscular dystrophy drug and a new variety of it. unlike most hearings, this one is being done virtually. it is prohibiting the use of cameras and choosing from the patient's segment by lottery who can speak up in diseases like this and many others, where it is very progressive and maybe has a sharp prognosis window. especially when there is something happening on the front that may be promising. why would you go from the nominal format to this, deemphasizing the patient component of it? >> centre, thank you for the question. technology is obviously exciting. this is a technology meeting, not a hearing. it is following the same rules we have for all of our advisory committees. the goal is to have experts give advice about the technology companies as they did present their data. people have a chance for an input but there is a limited amount of time. that is why there is a lot

califf: thank you. the senate committee on health education and labor pensions will come to order and we will year from two panels. we will hear from our first panel, don o'connell, the assistant secretary for preparedness and response. rochelle walensky the director of the center for disease control and dr. robert califf the commissioner of the food and drug administration. on our second panel we will hear from a doctor and robert wiseman and martin mccarrick. we have two very important panels. let me begin by thanking all of the folks that run the first panel. all of us know that the last three years have been unprecedented in our lifetimes. we dealt with the worst public health crisis in 100 years. i want to think all of you under those difficult circumstances for the work you did for the american people. today, our job is to take a look at at where we are today in terms of where we are preparing, god forbid, for another pandemic. and, the need to reauthorize the pandemic preparedness act later this

robert califf, commission of u.s. food and drug administration. dr. califf. of the fda. dr. califf: thank you for the opportunity to be here to discuss the importance of preparedness and how the fda can work with congress to ensure the country is ready for the next public health threat. pahpa recognizes the key role of the fda in public health preparedness and emergency response and we have used the authority under pahpa to support our national preparedness and response capabilities. however, there have been lessons learned about how these authorities can be modernized to ensure our actions could be even more effective. providing greater transparency on the supply chains and ensuring operational readiness and search capacity when any fda inspector and review staff and improving laboratory testing regulation our priorities that will enhance national security and public health preparedness. first, supply chains. there is a need for greater transparency in the supply chains of our medical products to improve resiliency and ensure continued access for critical medical products.

>> in terms of the short term, this is the highest priority. >> reporter: califf says the priority ising more manufacturers into the market and into the u.s. the association for accessible medicines who represents drugmakers says they too are deeply concerned, but added, policymakers must address shortages in a manner that is holistic and long-term solving for all aspects related to shortages. as for carrie, she's worried. her treatments are altered now using a different but similar drug with more side effects. >> there isn't anything that works as effectively. it is the drug i need. >> reporter: a critical problem, a solution unknown catie beck, nbc news, tallahassee, florida. >>> when we come back, the school custodian winning across the board teaching students how to succeed at chess and in life. >>> finally tonight, the school custodian teaching kids how to clean up the competition in chess kristen dahlgren explains >> reporter: at the end of the school day in hampton, maine, custodian david bishop puts down his mop. >> that was key right there. >> reporter: and starts teaching th

robert kayla --ca ;of --califf. dr. califf: thank you. the senate committee on health education and labor pensions will come to order and we will year from two panels. we will hear fro

califf is mistaken. in the snare you laid out for him there was no private sector market at all. you are talking about countermeasures where it was the give it was the sole purchaser. so the intellectual property the monopoly that's not what's going on.le thought about how we can charge the most for private individuals. individuals. all that doesut is give the company that the u.s. government funded more bargaining power with the united states when we purchase from them. that doesn't seem like a sensible thing. >> i'm not question following your logic. the original premise was it a try to get the company to commit significant resources to developing something, is a better student intellectual property whether not the u.s. will be the sole but in this setting we are taught about the initial, to jumpstart it. the premise of the discussion was is it better to give them an express in which you bet the farm on winning the prize if that you lose, or the better to give intellectual property protection and better to give them sort of kind of tradition intellectual, et cetera? >> i unders

testimony also raisedmi questions of why key facts about the crisis were omitted when commissioner califfmayne, and mr. yiannas testified before the energy and commerce committee last february, and in the so-called independent solomon report. today's hearing will continue the long overdue oversight of the food and drug administration's response to the infant formula crisis.nd we will get answers to why the fda has not been fully forthcoming with congress and the public. today's hearing will examine why it took more than four months for inspectors to arrive at the abbott plant in sturgis, michigan after babies started getting sick. we will determine why it took so long for the biden administration to take action to secure the infant formula suppll after a recall left shelves bare. why was the fda unprepared foror this crisis? why did they only inspect three of twenty-three infant formula manufacturing facilities in 2020? three of 23. why did they fail to investigate whistleblower warnings?te did the fda follow its regulatory protocols? did the fda respond quickly enough? was the fda's so-c

califf. thank you for starting our day with a wonderful keynote speech. [applause] we will now take a five-minute break while we set up for the next talk. five-minute break. >> hello, everyone. thank you dr. califf for the fibers speech. we're continuing our focus onn digital health. our next session will be on bridging thehe digital divide, disparities and diagnosis through telehealth. my name is betham mathews-bradshaw, and the vice president of research and patient engagement at the alliance for aging research. i'm excited to introduce our speaker, dr. nicol turner-lee, senior fellow of governments studies and director for the set of technology innovation at the brookings institution. where she researches echo access to technology, broadband to plummet and internet governance. her expertise is at the intersection of race, wealth, and technology with in the context of civil engagement, criminal justice and economic development. prior to work at the brookings institution, dr. turley has served as vice president to both a multicultural media telecom and i

why they are making the investment because the private sector model in these cases, as commissioner califf said earlier does not work. it is at least insufficient. we have to think creatively about how we can get better. prices can be recalibrated to provide special incentives. as our resources into this space, while also ensuring affordability and access on the back end. we could also do other things to promote inflammation -- to promote innovation like giving everywhere the people do not a product that contributions along the way. these are some lessons that have come out of the pandemic and that we must incorporate going forward. >> senator cassidy, did you want to introduce yours? >> we are joined by dr. marty mccarley, a researcher for the johns hopkins school of medicine and from john hopkins carey business school. dr. makar broke his research on health care and other issues ranging from health care to covid-19 and previously worked for the world health organization where he helped his surgery checklist which help reduce surgery related death around the world. he completed his medica

califf oversees the full breath of the fda's work portfolio and the execution of the federal food, drug and cosmetic act and other accessible laws that includes assuring the safety, effectiveness and security of human and veterinary drugs, vaccines and other biological products for human use and medical devices, the safety and security of the nation's food supply, cosmetics, dietary supplements, products that gave off electronic radiation and the regulation of tobacco products. he said a long and distinguished career as a physician, researcher and leader in the field of science and medicine. internationally recognizeda natt in some cardiovascular medicines, health outcomes research, healthcare, quality and clinical research and as the leader in the growing field of translational research which is key to ensuring the advancements in science, translate into medical care. we are very excited. [applause] >> thanks for that kind introduction. if i seem a little sluggish today i spent the weekend down at a funeral in my hometown in columbia south carolina. and it's not a bad thing. my uncle d

robert califf life before the senate h.e.l.p. committee on c-span, c-span now a free mobile video app and online at c-span.org. >> order your copy of the 118th congressional directory now available at c-spanshop.org. it's your access to the federal government with bio and contact information for every house and senate member and important information on congressional committees, the presidency cabinet, federal agencies and state governors. scan the code at the right to order your copy today. or go to c-spanshop.org. it's $29.95 plus shipping and handling and every purchase helps support our nonprofit operations. >> up next to director general of the world trade organization ngozi okonjo-iweala discusses global trade and geopolitics. hosted by american university here in washington, d.c. this is just over one hour. [inaudible conversations] [inaudible conversations] >> okay. good morning, everyone. i am randall henning, i serve as the faculty chair of the international economic relations program, and in dean absence is my post to

. >> they want florida to be more like califf, where the l.a. dodgers, they were about to honor an anti catholic group of drag queens who pretend to be nuns. >> that invitation was ultimately rescinded after a widespread backlash. here with reaction, i'll kick host tommy larin, fox business host dagen mcdowell. >> good to see this on wall street. he spent much time, my first twenty six years on the air talking about drag queens. now it's a drag queen. story hour now it's transition time. now it's gender identity. >> how did this all of a sudden we have congress members asking, can you define a woman for me, please, ma'am? >> and i never thought that would happen. this is also telling, though, that people are getting so agitated on the left that they can't have grown adult men wearing dresses and makeup, dancing for children. the fact that that upsets the left is really telling to me and really quite disgusting. but when we fight the culture, it's actually , to me a disservice to the term culture war. it shouldn't be a culture war. children shoul

robert califf life before the senate h.e.l.p.span now a free mobile video app and online at c-span.org. >> order your copy of the 118th congressional directory now available at c-spanshop.org. it's your access

. >> reporter: fda commissioner robert califf says drug shortages are getting worse because generic versionsedicines have become so inexpensive to consumers producing them is no longer profitable for manufacturers so many have stopped. he says the vast majority are imported quality control issues have also played a part. >> any market things get out of kilter and that's definitely happened here. >> reporter: are you guys working urgently to find some type of short-term solution. >> in terms of short term this is the highest priority. >> reporter: he says the highest priority is to bring more manufacturers into the market and into the u.s the association for accessible medicine who represents drugmakers say they took are deeply concerned but added policymakers must address shortages in a manner wholistic and long term, shoveling for aspects related to shortages as for her, she is worried her treatments are altered now using a different but similar drug with more side effects >> there isn't anything that works as effectively it is the drug i need. >> reporter: a critical problem, a solution un

robert califf and others at a symposium hosted at the national health council in washington, d.c. >> we never had a divorced president or a president who was married to somebody who had been divorced until gerald ford and betty ford. and then reagan, of course, had been divorced. and then we kind of tolerated clinton because as james carville said, it's only sex. and here is trump on, what, wife number three or four, i lost count and all of these accusations made against him. and i just think at a certain point character overcomes everything else and i am not certainly not supporting him in the next election. i hope somebody younger and better character qualities gets the nomination. >> calhomas with his book "a watchman in the night" sunday on "q&a." you can listen to "q&a" on our free c-span app.